The past 5–10 years have brought in a new era in the care of patients with thyroid cancer,
with the introduction of transformative diagnostic and management options. Several …

Differentiated thyroid carcinoma (DTC) is the most common endocrine cancer. Particularly
the incidence of small clinically indolent tumors has been increasing significantly during the …

Abstract The guidelines Thyroid Cancer 2022 are prepared based on previous Polish
recommendations updated in 2018. They consider international guidelines—American …

Purpose Concern is growing about long-term side effects of differentiated thyroid cancer
treatment, most notably radioactive iodine (RAI) therapy. However, published studies on the …

Simple Summary Radioactive iodine treatment is the oldest targeted therapy for
differentiated thyroid cancer. It can be used for normal thyroid remnant ablation (in order to …

Simple Summary Increased oxidative stress (OS) has been implicated as a relevant risk
factor for cancer development and progression. The incidence of differentiated thyroid …

A task force of the United Italian society of Endocrine Surgery (SIUEC) was commissioned to
review the position statement on diagnostic, therapeutic and health‑care management …

During the last few years, especially since the American Thyroid Association guidelines was
released in 2015, there has been an intense debate on the management of thyroid cancer …

Simple Summary Surgery is generally the treatment of choice for locoregional recurrences of
well-differentiated thyroid carcinomas, but other therapies can be considered on an …

Simple Summary No clinical studies have investigated the effect of radioiodine (131I)-
targeted therapy on the potential markers of ongoing inflammation in patients with DTC …